医薬品リファレンス
Reboxetine
Reboxetine is a medicine in the class central nervous system. It is used for depression.
- 薬効分類: Central Nervous System
- 効能・効果: depression
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
要点
- 薬効分類
- Central Nervous System
- 一般的な剤形
- 錠剤
- 一般的な規格
- 4 mg
- 商品名
- 2
- 国・市場
- 2
何に使われるか
作用のしくみ
Reboxetine is primarily used to treat depression but has also been found useful in the treatment of narcolepsy and panic disorders. Reboxetine is a selective inhibitor of noradrenaline reuptake. It inhibits noradrenaline reuptake in vitro to a similar extent to the tricyclic antidepressant desmethylimipramine.
成人の通常用量（添付文書の要約）
The recommended therapeutic dose is 4 mg twice a day (b.i.d.) i.e.8 mg/day administered orally, maximum daily dose should not exceed 12 mg/day.
妊娠と授乳
- 妊娠
- Unknown No trial data; a very limited number of exposed pregnancies showed no adverse effects. Animal studies showed no harm apart from impaired growth in rat pups. Not approved in the US. UK label: use only if benefits outweigh risks; better-studied antidepressants are preferred.
- 授乳
- Unknown Passes into milk in low amounts; no adverse effects reported in breastfed infants (doses up to 10 mg daily). UK label: consider if benefits outweigh the risk. LactMed: use with careful infant monitoring. SSRIs such as sertraline have more data.
報告されている副作用
- Dry mouth
- Insomnia
- Constipation
- Decreased appetite
- Dizziness
- Agitation
注意が必要な方
- The starting dose in patients with renal or hepatic insufficiency should be 2 mg b.i.d which can be increased based on patient tolerance.
妊娠中または授乳中であること、腎臓や肝臓の病気、アレルギー、ほかに使用しているすべての薬やサプリメントについて、薬剤師または医師にお伝えください。
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Reboxetineの完全なモノグラフ（用量、妊娠・授乳、副作用、警告、すべての相互作用）を表示できます。
- Dosing by age, kidney and liver function, and further dose lines
- Paediatric dosing
- Dosing in older adults
- Patient counselling points
- Food interactions
WebでPro+を14日間無料でお試し。カード登録不要。
同じ分類のほかの薬剤
よくある質問
What is Reboxetine used for?
Reboxetine is a medicine in the class central nervous system. It is used for Depression.
What side effects have been reported with Reboxetine?
Dry mouth, Insomnia, Constipation, Decreased appetite, Dizziness, Agitation.
Can Reboxetine be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. No trial data; a very limited number of exposed pregnancies showed no adverse effects. Animal studies showed no harm apart from impaired growth in rat pups. Not approved in the US. UK label: use only if benefits outweigh risks; better-studied antidepressants are preferred. Breastfeeding: Unknown. Passes into milk in low amounts; no adverse effects reported in breastfed infants (doses up to 10 mg daily). UK label: consider if benefits outweigh the risk. LactMed: use with careful infant monitoring. SSRIs such as sertraline have more data.
What does Reboxetine interact with?
MediHelp does not list a checked interaction for Reboxetine yet. Always tell your pharmacist about every medicine you take.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
